Yes, they are still trying to make recovery possible

I can’t make it up.

Although The New York Times tried. On Monday, the Times published a piece bemoaning the difficulty Americans are supposedly facing in getting new Covid reinforcements. The owner:

This is a total reversal of reality. Or, as the kids say, LOL.

The Centers for Disease Control no longer provides updated statistics on Covid vaccinations. But some state health departments still provide weekly data. They show that even in blue states that once embraced mRNAs, the demand for hits is almost zero.

The failure comes despite public health and media exhortations and massive advertising campaigns by jab companies. Health bureaucrats and Pfizer and Moderna hoped that positioning the Covid shots as annual shots alongside flu shots would increase demand.

They were wrong.

—

(Because the truth won’t tell itself. But I will, for 20 cents a day. Join me!)

—

Here is the reality. Weekly data from three big blue states — Colorado, Washington and Massachusetts — show that demand for shots is trailing even the dismal launch of “bivalent” mRNA vaccines last fall, which resulted in only 17 percent from the Americans they received blows.

Colorado gave 540,000 cases of Covid in September and October. That number may sound like a lot, but it’s less than 10 percent of the state’s population, and lags the figure for the same period in 2022 by about a quarter.

Likewise, Washington State administered 840,000 hits as of early November, or 11 percent of its population, a 30 percent decline compared to 2022.

And Massachusetts, which is extraordinarily liberal and almost had adult vaccination by 2021, is in 12 percent – compared to 27% of flu shots.

Also, it appears that every state has exhausted the demand. Although the strikes were implemented slightly later in 2023 than in 2022, administrations reached lower levels in October and are now declining faster.

—

(Less is more. Except if you’re a Moderna or Pfizer shareholder. Note that the pink link, the number of hits given in 2023, dropped particularly quickly last week.)

(SOURCE)

—

In fact, data from the 2022-23 bivalent booster campaign suggests that most people who want to do it this year have already done so, even without explaining the surprisingly rapid drop in demand in recent days.

Washington and Massachusetts will likely struggle to reach 20 percent coverage, while Colorado may not even reach 15 percent. These numbers are surprisingly low, given that all three states ranked in the top 15 nationally during the initial rollout of the mRNA.

Last month, Pfizer projected it 17 percent of Americans, or about 55 million people, would get the booster this year, the same number who got the bivalent. The company lowered that projection from 24 percent a few weeks before.

But updated state data suggests the new number is still too high. The number is more likely to be 9 to 13 percent of Americans, or 30 to 45 million shots in total.

—

The drop in demand comes even as Pfizer and Moderna have run massive advertising campaigns for the boosters this fall.

Pfizer cleverly and cynically tried to tie its shot to the flu shot, using Travis Kelce, a 34-year-old football player whose age and robust health make him a particularly unsuitable spokesperson. Surely Kelce is more likely to have mRNA-related myocarditis than a serious complication of Covid.

Meanwhile, Moderna ran a really weird, if catchy, campaign that includes the tagline “Spikevax that body.” (Yes, Spikevax is the official name for Moderna’s mRNA-1273 Covid jab, another dubious choice, and one that the company rarely used before this fall. Pfizer’s BNT162b2 shot is officially known as Comirnaty , or as I used to refer to it as Twitter“Come here naughty.”)

—

(Won’t Spikevax protect everyone? Now tell us!)

SOURCE

—

Wall Street knows demand has soared and fled Pfizer and Moderna. Both companies are now trading below their November 2020 levels, before they published the results of clinical trials that seemed to show that the injections work.

However, in the fantasy world of the media, the real obstacle to Covid vaccinations is not demand, but administrative obstacles to overwhelming demand.

In its Monday article, the Times blamed “distribution problems” and “stuck with the new billing codes” in the second paragraph, the fact that the jabs “have been slow to reach doctors’ offices” in the fourth and closing of mass vaccination. places in the eighth.

Only in the ninth paragraph of the article did the Times acknowledge “the waning interest in vaccination,” and only as a factor that “has made it difficult for physicians and pharmacists to properly judge the demand in time to ask for vaccines”.

If the Times really wanted to report the truth about mRNAs, it would spend less time making excuses for the overwhelming public rejection of the boosters and more time investigating the root causes.

Unfortunately, three years after the largest public health experiment in history – the dosing of more than 1 billion people with a new and barely proven biotechnology – the newspaper and its elite media competitors they remain committed to burying their collective heads in the sand.

Covid hits may not be good for protection. But they sure have immunized a large portion of journalists from anything resembling reality.